INTRODUCTION: Polymyxins have become the drug of choice for treatment of multidrug-resistant gram-negative bacilli infections in Singapore, simply because these pathogens are only susceptible to either aminoglycosides and polymyxins, or polymyxins only. Furthermore, there is no new antibiotic in the pipeline that targets these difficult-to-treat infections. MATERIALS AND METHODS: All published literatures (up to end of February 2008) regarding polymyxins are included for review. RESULTS: This review serves to give a summary of polymyxins from the current available literature, highlighting relevant clinical studies and information that help to guide informed prescription of polymyxins, should the need arise. CONCLUSIONS: However, there are substantial information gaps that needed to be filled urgently, to preserve the clinical utility of this very last line of antibiotic.
INTRODUCTION: Polymyxins have become the drug of choice for treatment of multidrug-resistant gram-negative bacilli infections in Singapore, simply because these pathogens are only susceptible to either aminoglycosides and polymyxins, or polymyxins only. Furthermore, there is no new antibiotic in the pipeline that targets these difficult-to-treat infections. MATERIALS AND METHODS: All published literatures (up to end of February 2008) regarding polymyxins are included for review. RESULTS: This review serves to give a summary of polymyxins from the current available literature, highlighting relevant clinical studies and information that help to guide informed prescription of polymyxins, should the need arise. CONCLUSIONS: However, there are substantial information gaps that needed to be filled urgently, to preserve the clinical utility of this very last line of antibiotic.
Authors: Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock Journal: Cold Spring Harb Perspect Med Date: 2016-10-03 Impact factor: 6.915
Authors: Yiying Cai; Tze-Peng Lim; Jocelyn Teo; Suranthran Sasikala; Winnie Lee; Yanjun Hong; Eric Chun Yong Chan; Thean Yen Tan; Thuan-Tong Tan; Tse Hsien Koh; Li Yang Hsu; Andrea L Kwa Journal: Antimicrob Agents Chemother Date: 2016-08-22 Impact factor: 5.191
Authors: Kamilia Abdelraouf; Kirk H Braggs; Taijun Yin; Luan D Truong; Ming Hu; Vincent H Tam Journal: Antimicrob Agents Chemother Date: 2012-06-11 Impact factor: 5.191
Authors: Kamilia Abdelraouf; Jie He; Kimberly R Ledesma; Ming Hu; Vincent H Tam Journal: Antimicrob Agents Chemother Date: 2012-08-20 Impact factor: 5.191